Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Convalescent Plasma for the Treatment of Severe SARS-CoV-2 Infection: A Randomized, Open Label Clinical Trial

NCT04391101 is registered in ClinicalTrials.gov with Hospital San Vicente Fundación as lead sponsor.

NCT NCT04391101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04391101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Convalescent Plasma for the Treatment of Severe SARS-CoV-2 Infection: A Randomized, Open Label Clinical Trial
Lead sponsor
Hospital San Vicente Fundación
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2020
Completion date
December 31, 2021
Enrollment
231 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2